인쇄하기
취소
|
In the hyperlipidemia field, Lipitor(developed by Pfizer) has remained strong. Its gap with Crestor, the second largest drug, has been expended since the beginning of the year.
Lipitor, which almost got caught, was able to broaden the gap with Crestor(developed by AstraZeneca).
According to the UBIST’s data on the 22nd, outpatients prescriptions of Lipitor recorded KRW 33.5 billion increased ...